慶應義塾研究者情報データベース

経歴 【 表示 ／ 非表示 】

経歴 【 表示 ／ 非表示 】

• 2016年04月

  -

  2022年03月

  横浜労災病院, 薬剤部, 薬剤師

• 2022年04月

  -

  2023年03月

  帝京平成大学, 薬学部薬学科, 助教

• 2022年04月

  -

  2023年12月

  東京都立小児総合医療センター, 薬剤科, 薬剤師

• 2023年04月

  -

  2024年03月

  慶應義塾大学, 薬学部 医薬品情報学講座, 研究員

• 2024年01月

  -

  継続中

  東京都立墨東病院, 薬剤科, 薬剤師

全件表示 >>

学歴 【 表示 ／ 非表示 】

学歴 【 表示 ／ 非表示 】

• 2010年04月

  -

  2016年03月

  東京薬科大学, 薬学部, 医療薬学科

• 2018年04月

  -

  2022年03月

  帝京平成大学, 薬学研究科, 博士課程

学位 【 表示 ／ 非表示 】

学位 【 表示 ／ 非表示 】

• 博士（薬学）, 帝京平成大学, 課程, 2022年03月

免許・資格 【 表示 ／ 非表示 】

免許・資格 【 表示 ／ 非表示 】

• 薬剤師, 2016年

研究分野 【 表示 ／ 非表示 】

研究分野 【 表示 ／ 非表示 】

• ライフサイエンス / 医療薬学

研究キーワード 【 表示 ／ 非表示 】

研究キーワード 【 表示 ／ 非表示 】

• 医薬品情報学

• 臨床薬学

論文 【 表示 ／ 非表示 】

論文 【 表示 ／ 非表示 】

• A patient-centered approach to developing and validating a natural language processing model for extracting patient-reported symptoms

  Watabe S., Yanagisawa Y., Sayama K., Yokoyama S., Someya M., Taniguchi R., Yada S., Aramaki E., Kizaki H., Tsuchiya M., Imai S., Hori S.

  Scientific Reports 15 （ 1 ）  2025年12月

  　概要を見る

  Patient-reported symptoms provide valuable insights into patient experiences and can enhance healthcare quality; however, effectively capturing them remains challenging. Although natural language processing (NLP) models have been developed to extract adverse events and symptoms from medical records written by healthcare professionals, limited studies have focused on models designed for patient-generated narratives. This study developed an NLP model to extract patient-reported symptoms from pharmaceutical care records and validated its effectiveness in analyzing diverse patient-generated narratives. The target dataset comprised “Subjective” sections of pharmaceutical care records created by community pharmacists for patients prescribed anticancer drugs. Two annotation guidelines were applied to develop robust ground-truth data, which was used to develop and evaluate a new transformer-based named entity recognition model. Model performance was compared with that of an existing tool for Japanese clinical texts and tested on external patient-generated blog data to evaluate generalizability. The newly developed BERT-CRF model significantly outperformed the existing model, achieving an F1 score > 0.8 on pharmaceutical care records and extracting > 98% of physical symptom entries from patient blogs, with a 20% improvement over the existing tool. These findings highlight the importance of fine-tuning models using patient-specific narrative data to capture nuanced and colloquial symptom expressions.

  • Access to Document (DOI)

• Improving Systematic Review Updates With Natural Language Processing Through Abstract Component Classification and Selection: Algorithm Development and Validation

  Hasegawa T., Kizaki H., Ikegami K., Imai S., Yanagisawa Y., Yada S., Aramaki E., Hori S.

  Jmir Medical Informatics 13 2025年03月

  　概要を見る

  Background: A challenge in updating systematic reviews is the workload in screening the articles. Many screening models using natural language processing technology have been implemented to scrutinize articles based on titles and abstracts. While these approaches show promise, traditional models typically treat abstracts as uniform text. We hypothesize that selective training on specific abstract components could enhance model performance for systematic review screening. Objective: We evaluated the efficacy of a novel screening model that selects specific components from abstracts to improve performance and developed an automatic systematic review update model using an abstract component classifier to categorize abstracts based on their components. Methods: A screening model was created based on the included and excluded articles in the existing systematic review and used as the scheme for the automatic update of the systematic review. A prior publication was selected for the systematic review, and articles included or excluded in the articles screening process were used as training data. The titles and abstracts were classified into 5 categories (Title, Introduction, Methods, Results, and Conclusion). Thirty-one component-composition datasets were created by combining 5 component datasets. We implemented 31 screening models using the component-composition datasets and compared their performances. Comparisons were conducted using 3 pretrained models: Bidirectional Encoder Representations from Transformer (BERT), BioLinkBERT, and BioM- Efficiently Learning an Encoder that Classifies Token Replacements Accurately (ELECTRA). Moreover, to automate the component selection of abstracts, we developed the Abstract Component Classifier Model and created component datasets using this classifier model classification. Using the component datasets classified using the Abstract Component Classifier Model, we created 10 component-composition datasets used by the top 10 screening models with the highest performance when implementing screening models using the component datasets that were classified manually. Ten screening models were implemented using these datasets, and their performances were compared with those of models developed using manually classified component-composition datasets. The primary evaluation metric was the F10-Score weighted by the recall. Results: A total of 256 included articles and 1261 excluded articles were extracted from the selected systematic review. In the screening models implemented using manually classified datasets, the performance of some surpassed that of models trained on all components (BERT: 9 models, BioLinkBERT: 6 models, and BioM-ELECTRA: 21 models). In models implemented using datasets classified by the Abstract Component Classifier Model, the performances of some models (BERT: 7 models and BioM-ELECTRA: 9 models) surpassed that of the models trained on all components. These models achieved an 88.6% reduction in manual screening workload while maintaining high recall (0.93). Conclusions: Component selection from the title and abstract can improve the performance of screening models and substantially reduce the manual screening workload in systematic review updates. Future research should focus on validating this approach across different systematic review domains.

  • Access to Document (DOI)

• Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition

  Yanagisawa Y., Watabe S., Yokoyama S., Sayama K., Kizaki H., Tsuchiya M., Imai S., Someya M., Taniguchi R., Yada S., Aramaki E., Hori S.

  Jmir Cancer （JMIR Publications Inc.）  11   e69663 - e69663 2025年03月

  筆頭著者

  　概要を見る

  Background: Androgen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration for patients with CRPC. Despite the importance of monitoring, few studies have identified which AEs can be captured and assessed in community pharmacies, where pharmacists in Japan dispense medications, provide counseling, and monitor potential AEs for outpatients prescribed ARATs. Therefore, we anticipated that a named entity recognition (NER) system might be used to extract AEs recorded in pharmaceutical care records generated by community pharmacists. Objective: This study aimed to evaluate whether an NER system can effectively and systematically identify AEs in outpatients undergoing ARAT therapy by reviewing pharmaceutical care records generated by community pharmacists, focusing on assessment notes, which often contain detailed records of AEs. Additionally, the study sought to determine whether outpatient pharmacotherapy monitoring can be enhanced by using NER to systematically collect AEs from pharmaceutical care records. Methods: We used an NER system based on the widely used Japanese medical term extraction system MedNER-CR-JA, which uses Bidirectional Encoder Representations from Transformers (BERT). To evaluate its performance for pharmaceutical care records by community pharmacists, the NER system was first applied to 1008 assessment notes in records related to anticancer drug prescriptions. Three pharmaceutically proficient researchers compared the results with the annotated notes assigned symptom tags according to annotation guidelines and evaluated the performance of the NER system on the assessment notes in the pharmaceutical care records. The system was then applied to 2193 assessment notes for patients prescribed ARATs. Results: The F<inf>1</inf>-score for exact matches of all symptom tags between the NER system and annotators was 0.72, confirming the NER system has sufficient performance for application to pharmaceutical care records. The NER system automatically assigned 1900 symptom tags for the 2193 assessment notes from patients prescribed ARATs; 623 tags (32.8%) were positive symptom tags (symptoms present), while 1067 tags (56.2%) were negative symptom tags (symptoms absent). Positive symptom tags included ARAT-related AEs such as “pain,” “skin disorders,” “fatigue,” and “gastrointestinal symptoms.” Many other symptoms were classified as serious AEs. Furthermore, differences in symptom tag profiles reflecting pharmacists’ AE monitoring were observed between androgen synthesis inhibition and androgen receptor signaling inhibition. Conclusions: The NER system successfully extracted AEs from pharmaceutical care records of patients prescribed ARATs, demonstrating its potential to systematically track the presence and absence of AEs in outpatients. Based on the analysis of a large volume of pharmaceutical medical records using the NER system, community pharmacists not only detect potential AEs but also actively monitor the absence of severe AEs, offering valuable insights for the continuous improvement of patient safety management.

  • Access to Document (DOI)

• 病院における医薬品関連のインシデントレポート分析の現状と課題に関する全国調査

  江原 沙也加, 柳澤 友希, 木﨑 速人, 今井 俊吾, 安室 修, 舟越 亮寛, 堀 里子

  医療薬学 （Japanese Society of Pharmaceutical Health Care and Sciences）  51 （ 1 ） 10 - 19 2025年01月

  査読有り,  ISSN  1346-342X

  • Access to Document (DOI)

• Analysis of Overdose-related Posts on Social Media

  Sato R., Tsuchiya M., Ichiyama R., Hisamura S., Watabe S., Yanagisawa Y., Nishiyama T., Yada S., Aramaki E., Kizaki H., Imai S., Hori S.

  Yakugaku Zasshi （Pharmaceutical Society of Japan）  144 （ 12 ） 1125 - 1135 2024年12月

  ISSN  0031-6903

  　概要を見る

  Intentional overdose (OD) of over-the-counter (OTC) and prescription drugs is becoming a significant social issue all over the world. While previous research has focused on drug misuse, there has been limited analysis using social networking service data. This study aims to analyze posts related to a drug overdose on Twitter^® (X^®) to understand the characteristics and trends of drug misuse, and to examine the applicability of social media in understanding the current situation of OD through natural language processing techniques. We collected posts in Japanese containing the term“OD”from January 10 to February 8, 2023, and analyzed 30203 posts. Using a pre-trained, fine-tuned bidirectional encoder representations from transformers (BERT) model, we classified the posts into categories, including direct mentions of OD. We examined the content for drug types and emotional context. Among the 5283 posts categorized as“Posts describing ODing,”about one-third included specific drug names or related terms. The most frequently mentioned OTC drugs included active ingredients such as codeine, dextromethorphan, ephedrine, and diphenhydramine. Prescription drugs, particularly benzodiazepines and pregabalin, were also common. Tweets peaked at midnight, suggesting a link between negative emotions and potential OD incidents. Our classifier showed high accuracy in distinguishing OD-related posts. Analyzing Twitter^® posts provides valuable insights into the patterns and emotional contexts of drug misuse. Monitoring social networking services for OD-related content could help identify high-risk individuals and inform prevention strategies. Enhanced monitoring and public awareness are crucial to reducing the risks associated with both OTC and prescription drug misuse.

  • Access to Document (DOI)

全件表示 >>